Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.
about
Novel personalized therapies for cystic fibrosis: treating the basic defect in all patients.Heme oxygenase-1-mediated autophagy protects against pulmonary endothelial cell death and development of emphysema in cadmium-treated miceAcquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceImmunohistochemical Detection of Markers for Translational Studies of Lung Disease in Pigs and HumansPilot evaluation of ivacaftor for chronic bronchitis.Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis.Hydrator Therapies for Chronic Bronchitis. Lessons from Cystic FibrosisNano-based rescue of dysfunctional autophagy in chronic obstructive lung diseases.Dendrimer-based selective autophagy-induction rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection in cystic fibrosis.Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.The therapeutic potential of CFTR modulators for COPD and other airway diseases.Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
P2860
Q35286065-1775A95C-BF20-47E4-BC9E-779F58DCD04CQ35916871-894D4826-BF37-4E39-A0BF-F5BE3CA15EEEQ36567237-07513196-0708-49DC-87D6-CA4B6C0A1FFDQ36723157-05319B19-DE01-4EAA-9681-A039725A5260Q37028545-3CE6B8C7-836F-4703-9781-A03D38349886Q37241561-BF1989FF-598B-4580-BA95-050B99658D47Q37241563-8B9A3957-8423-4C2D-A9A0-78EC9D2F9508Q38937131-62FD2DD4-8E86-4409-B766-48B2F2B8C534Q40048899-229B8A03-A5B8-485A-AF82-13A363D55692Q41710343-F894F344-BA92-4F0D-98FE-FF90D0A3D01CQ43062795-7E78AA69-AD38-4B55-97ED-ABE60EB1C44BQ49073386-7D62A58C-D7FE-4E6A-826D-15CDD04946DCQ50046887-D0DA5EB6-1DF2-4334-87DF-372F0972C945Q54962564-0B4992D9-C29A-46B4-8D58-249425581A3BQ58618239-E8687737-44C4-46B6-A10F-6AD957BA4BE3
P2860
Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@ast
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@en
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@nl
type
label
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@ast
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@en
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@nl
prefLabel
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@ast
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@en
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1433
P1476
Acquired defects in CFTR-depen ...... obstructive pulmonary disease.
@en
P2093
Clifford A Courville
Frank J Accurso
Mark T Dransfield
Sherry Tidwell
Steven M Rowe
P2860
P2888
P356
10.1186/1465-9921-15-25
P577
2014-02-25T00:00:00Z
P5875
P6179
1003692136